Squarepoint’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-181,231
| Closed | -$11.2M | – | 4419 |
|
|
2025
Q3 | $11.4M | Sell |
181,231
-132,781
| -42% | -$9.27M | 0.01% | 1013 |
|
|
2025
Q2 | $23.4M | Buy |
314,012
+310,913
| +10,033% | +$24.4M | 0.02% | 695 |
|
|
2025
Q1 | $273K | Sell |
3,099
-12,572
| -80% | -$1.19M | ﹤0.01% | 3806 |
|
|
2024
Q4 | $1.43M | Sell |
15,671
-226,335
| -94% | -$23.2M | ﹤0.01% | 2730 |
|
|
2024
Q3 | $27.1M | Buy |
242,006
+238,818
| +7,491% | +$23.9M | 0.04% | 465 |
|
|
2024
Q2 | $312K | Sell |
3,188
-27,559
| -90% | -$2.73M | ﹤0.01% | 3401 |
|
|
2024
Q1 | $3.08M | Sell |
30,747
-37,302
| -55% | -$3.28M | 0.01% | 1808 |
|
|
2023
Q4 | $6.11M | Buy |
68,049
+16,943
| +33% | +$1.35M | 0.01% | 1268 |
|
|
2023
Q3 | $3.92M | Buy |
51,106
+29,704
| +139% | +$2.46M | 0.01% | 1338 |
|
|
2023
Q2 | $1.79M | Sell |
21,402
-59,169
| -73% | -$4.81M | 0.01% | 1724 |
|
|
2023
Q1 | $6.8M | Buy |
80,571
+31,948
| +66% | +$2.74M | 0.03% | 717 |
|
|
2022
Q4 | $3.96M | Sell |
48,623
-32,789
| -40% | -$2.64M | 0.02% | 956 |
|
|
2022
Q3 | $5.78M | Buy |
+81,412
| New | +$7.32M | 0.03% | 672 |
|
|
2022
Q2 | – | Sell |
-21,880
| Closed | -$2.27M | – | 3000 |
|
|
2022
Q1 | $2.45M | Sell |
21,880
-63,821
| -74% | -$7.48M | 0.01% | 1037 |
|
|
2021
Q4 | $10.4M | Sell |
85,701
-108,039
| -56% | -$12M | 0.03% | 507 |
|
|
2021
Q3 | $19.5M | Buy |
193,740
+141,420
| +270% | +$15.6M | 0.06% | 309 |
|
|
2021
Q2 | $6.11M | Buy |
52,320
+45,863
| +710% | +$5.51M | 0.02% | 641 |
|
|
2021
Q1 | $711K | Buy |
6,457
+2,890
| +81% | +$314K | ﹤0.01% | 1764 |
|
|
2020
Q4 | $358K | Buy |
+3,567
| New | +$331K | ﹤0.01% | 2077 |
|
|
2020
Q2 | – | Sell |
-141,049
| Closed | -$6.57M | – | 2299 |
|
|
2020
Q1 | $6.57M | Buy |
141,049
+124,972
| +777% | +$8.03M | 0.17% | 135 |
|
|
2019
Q4 | $1.27M | Sell |
16,077
-142,299
| -90% | -$10.9M | 0.01% | 1189 |
|
|
2019
Q3 | $11.7M | Buy |
158,376
+52,190
| +49% | +$3.75M | 0.1% | 244 |
|
|
2019
Q2 | $8.26M | Sell |
106,186
-296,017
| -74% | -$22.5M | 0.08% | 295 |
|
|
2019
Q1 | $30.5M | Buy |
402,203
+294,783
| +274% | +$23.4M | 0.32% | 59 |
|
|
2018
Q4 | $7.85M | Sell |
107,420
-84,406
| -44% | -$6.73M | 0.09% | 284 |
|
|
2018
Q3 | $18.4M | Buy |
191,826
+91,650
| +91% | +$9.09M | 0.22% | 114 |
|
|
2018
Q2 | $10M | Buy |
100,176
+12,880
| +15% | +$1.36M | 0.13% | 225 |
|
|
2018
Q1 | $9.22M | Buy |
87,296
+61,264
| +235% | +$6.19M | 0.15% | 188 |
|
|
2017
Q4 | $2.41M | Buy |
+26,032
| New | +$2.37M | 0.04% | 485 |
|
|
2017
Q1 | – | Sell |
-45,807
| Closed | -$3.44M | – | 1615 |
|
|
2016
Q4 | $3.44M | Buy |
45,807
+29,565
| +182% | +$2.14M | 0.14% | 168 |
|
|
2016
Q3 | $1.1M | Sell |
16,242
-18,020
| -53% | -$1.21M | 0.07% | 323 |
|
|
2016
Q2 | $2.33M | Buy |
34,262
+18,323
| +115% | +$1.35M | 0.15% | 153 |
|
|
2016
Q1 | $1.15M | Buy |
15,939
+1,388
| +10% | +$90.9K | 0.09% | 334 |
|
|
2015
Q4 | $982K | Buy |
14,551
+1,551
| +12% | +$109K | 0.11% | 270 |
|
|
2015
Q3 | $841K | Buy |
+13,000
| New | +$960K | 0.21% | 136 |
|
|
2015
Q2 | – | Sell |
-22,559
| Closed | -$1.56M | – | 502 |
|
|
2015
Q1 | $1.56M | Buy |
22,559
+12,324
| +120% | +$890K | 0.55% | 39 |
|
|
2014
Q4 | $776K | Buy |
+10,235
| New | +$809K | 0.75% | 39 |
|
Other funds holding EMN
VPM
VCM
Squarepoint's EMN Position: Q4 2025 in Review
Squarepoint sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 181,231 shares — an estimated $11.2M sold.
Squarepoint first reported a position in EMN in Q4 2014 and held it in 37 quarters. The position peaked at $30.5M in Q1 2019. 630 funds tracked by Wall St. Rank hold EMN as of Q4 2025.
- Squarepoint reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
- Squarepoint sold 181,231 Eastman Chemical shares in Q4 2025, an estimated $11.2M.
- Squarepoint first reported a position in Eastman Chemical in Q4 2014 and held it in 37 quarters.
- Squarepoint's Eastman Chemical position peaked at $30.5M in Q1 2019.
- 630 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.
Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.